Nxera Pharma Co., Ltd. (4565.T) JPX

897.00

-20(-2.18%)

Updated at February 20 03:30PM

Currency In JPY

Valuation

Market Cap74.66B
Enterprise Value115.18B
P/E Ratio-6.47
PEG Ratio0.06
Price/Sales Ratio2.74
Price/Book Ratio1.33
Enterprise/Revenue4.11
Enterprise/EBITDA-57.21

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin-0.42
Operating Margin-0.28

Management Effectiveness

Return On Assets-0.09
Return On Equity-0.19

Income Statement

Revenue29.62B
Revenue/Share327.88
Gross Profit21.42B
EBITDA-3.91B
Net Income-12.53B
Diluted EPS-138.8

Balance Sheet

Total Cash20.36B
Total Cash/Share225.47
Total Debt60.89B
Total Debt/Equity1
Current Ratio2.54
Book Value Per Share675.32

Price History

52-Week Change6.79
52-Week High1,048
52-Week Low668
Moving Average 50 Days837.56
Moving Average 200 Days889.55

Statistics

Average Volume905,405
Shares Outstanding90.49M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor4:1
Last Split DateJune 27, 2018